총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Delcath Systems, Inc. (DCTH), 포함 43 건 매수 및 3 건 매도. 내부자 매수 총액은 $3.87B 내부자 매도 총액은 $443.45K.
최근 활동이 있는 주요 내부자에는 Pennell Sandra, Michel Gerard J, Vukovic Vojo. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — DCTH
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2026-03-06 |
Pennell Sandra |
Chief Financial Officer |
정보 매수 |
5,533 |
$9.04 |
$50.02K |
77,018 |
| 2026-03-02 |
Michel Gerard J |
Chief Executive Officer |
정보 매수 |
11,200 |
$8.96 |
$100.31K |
342,034 |
| 2026-02-17 |
Michel Gerard J |
Chief Executive Officer |
RSU 부여 |
97,500 |
- |
- |
97,500 |
| 2026-02-17 |
Vukovic Vojo |
Chief Medical Officer |
RSU 부여 |
28,250 |
- |
- |
28,250 |
| 2026-02-17 |
Pennell Sandra |
Chief Financial Officer |
RSU 부여 |
28,250 |
- |
- |
28,250 |
| 2026-02-17 |
Muir Kevin |
GM Interventional Oncology |
RSU 부여 |
28,250 |
- |
- |
28,250 |
| 2026-02-17 |
Hoffman David L. |
Gen'l Counsel, Cco & Secy |
RSU 부여 |
28,250 |
- |
- |
28,250 |
| 2026-02-17 |
Rook Martha S. |
Chief Operating Officer |
RSU 부여 |
28,250 |
- |
- |
28,250 |
| 2025-11-21 |
Sylvester John Richard |
Director |
정보 매수 |
4,386 |
$8.89 |
$38.99K |
14,936 |
| 2025-11-11 |
Michel Gerard J |
Chief Executive Officer |
정보 매수 |
11,500 |
$8.53 |
$98.05K |
330,834 |
| 2025-06-12 |
Vukovic Vojo |
Chief Medical Officer |
옵션 행사 (매도) |
42,000 |
$4.78 |
$200.76K |
58,500 |
| 2025-05-15 |
Czerepak Elizabeth |
Director |
RSU 부여 |
22,500 |
$16.05 |
$361.13K |
22,500 |
| 2025-05-15 |
Salamon Steven A J |
Director |
RSU 부여 |
22,500 |
$16.05 |
$361.13K |
22,500 |
| 2025-05-15 |
Martell Bridget A |
Director |
RSU 부여 |
22,500 |
$16.05 |
$361.13K |
22,500 |
| 2025-05-15 |
Sylvester John Richard |
Director |
RSU 부여 |
22,500 |
$16.05 |
$361.13K |
22,500 |
| 2025-05-15 |
Aharon Gil |
Director |
RSU 부여 |
22,500 |
$16.05 |
$361.13K |
22,500 |
| 2025-05-05 |
Rosalind Advisors, Inc. |
Director |
옵션 행사 (ITM) |
400,000 |
$10.00 |
$4M |
3,413,468 |
| 2025-05-05 |
Salamon Steven A J |
Director |
옵션 행사 (ITM) |
400,000 |
$10.00 |
$4M |
3,413,468 |
| 2025-05-05 |
Aharon Gil |
Director |
옵션 행사 (ITM) |
400,000 |
$10.00 |
$4M |
3,413,468 |
| 2025-02-07 |
Michel Gerard J |
Chief Executive Officer |
RSU 부여 |
390,000 |
$16.25 |
$6.34M |
390,000 |
| 2025-02-07 |
Vukovic Vojo |
Chief Medical Officer |
RSU 부여 |
113,000 |
$16.25 |
$1.84M |
113,000 |
| 2025-02-07 |
Pennell Sandra |
Chief Financial Officer |
RSU 부여 |
113,000 |
$16.25 |
$1.84M |
113,000 |
| 2025-02-07 |
Muir Kevin |
GM Interventional Oncology |
RSU 부여 |
113,000 |
$16.25 |
$1.84M |
113,000 |
| 2025-02-07 |
Hoffman David L. |
Gen'l Counsel, Cco & Secy |
RSU 부여 |
113,000 |
$16.25 |
$1.84M |
113,000 |
| 2025-02-07 |
Rook Martha S. |
Chief Operating Officer |
RSU 부여 |
113,000 |
$16.25 |
$1.84M |
113,000 |
| 2024-12-24 |
Rosalind Advisors, Inc. |
Director |
옵션 행사 |
603,954 |
$0.01 |
$6.04K |
1,323,919 |
| 2024-12-24 |
Aharon Gil |
Director |
옵션 행사 |
603,954 |
$0.01 |
$6.04K |
1,323,919 |
| 2024-12-24 |
Salamon Steven A J |
Director |
옵션 행사 |
603,954 |
$0.01 |
$6.04K |
1,323,919 |
| 2024-10-30 |
Rosalind Advisors, Inc. |
Director |
옵션 만료 |
- |
- |
- |
- |
| 2024-10-30 |
Salamon Steven A J |
Director |
옵션 만료 |
- |
- |
- |
- |
| 2024-10-30 |
Aharon Gil |
Director |
옵션 만료 |
- |
- |
- |
- |
| 2024-10-22 |
Michel Gerard J |
Chief Executive Officer |
옵션 행사 (매도) |
16,666 |
$6.00 |
$100K |
- |
| 2024-05-23 |
Stoll Roger G Phd |
Director |
주식 반환 |
19,682 |
$7.25 |
$142.69K |
- |
| 2024-05-23 |
Czerepak Elizabeth |
Director |
RSU 부여 |
22,500 |
$7.85 |
$176.63K |
22,500 |
| 2024-05-23 |
Salamon Steven A J |
Director |
RSU 부여 |
22,500 |
$7.85 |
$176.63K |
22,500 |
| 2024-05-23 |
Martell Bridget A |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2024-05-23 |
Martell Bridget A |
Director |
RSU 부여 |
22,500 |
$7.85 |
$176.63K |
22,500 |
| 2024-05-23 |
Sylvester John Richard |
Director |
RSU 부여 |
22,500 |
$7.85 |
$176.63K |
22,500 |
| 2024-05-23 |
Aharon Gil |
Director |
RSU 부여 |
22,500 |
$7.85 |
$176.63K |
22,500 |
| 2024-04-18 |
Rosalind Advisors, Inc. |
Director |
전환 (매수) |
991,615 |
- |
- |
2,763,468 |
| 2024-04-18 |
Rosalind Advisors, Inc. |
Director |
옵션 행사 (ITM) |
619,946 |
$0.01 |
$6.2K |
2,763,468 |
| 2024-04-18 |
Salamon Steven A J |
Director |
옵션 행사 (ITM) |
619,946 |
$6,199.46 |
$3.84B |
2,732,586 |
| 2024-04-18 |
Salamon Steven A J |
Director |
옵션 행사 (ITM) |
619,946 |
$0.01 |
$6.2K |
2,732,586 |
| 2024-04-18 |
Aharon Gil |
Director |
전환 (매수) |
991,615 |
- |
- |
2,681,271 |
| 2024-04-18 |
Aharon Gil |
Director |
옵션 행사 (ITM) |
619,946 |
$0.01 |
$6.2K |
2,681,271 |
| 2024-03-19 |
Michel Gerard J |
Chief Executive Officer |
RSU 부여 |
40,323 |
$3.72 |
$150K |
302,668 |
| 2024-03-19 |
Vukovic Vojo |
Chief Medical Officer |
RSU 부여 |
26,882 |
$3.72 |
$100K |
126,882 |
| 2024-03-19 |
Pennell Sandra |
SVP of Finance, Pfo and Pao |
RSU 부여 |
26,881 |
$3.72 |
$100K |
61,052 |
| 2024-03-19 |
Muir Kevin |
GM Interventional Oncology |
RSU 부여 |
13,441 |
$3.72 |
$50K |
18,582 |
| 2024-03-19 |
Hoffman David L. |
Gen'l Counsel, Cco & Secy |
RSU 부여 |
20,161 |
$3.72 |
$75K |
74,330 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
